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Farnesoid X receptor (FXR) is a protein that was shown to be in-
volved in controlling numerous metabolic pathways that include: 
maintaining bile acid, lipid and glucose homeostasis, preventing in-
testinal bacterial infection and modulating liver regeneration and 
tumorigenesis [1]. TI1e different roles played by FXR highlight poten-
tial new opportunities for using FXR as a drug target for different 
diseases [2]. ln this worl< we validate the use of FXR as a target for 
virtual docking simulation experiments. 
We used the docking softw·are Autodock 4 as it is acknowledged to 
be one of the most widely used in docking simulations [3]. The FXR 3 
-D structure used (PDB code: 10SH) in this study is co-crystaJlized 
with Fexaramine, a known high affinity agonist. Before the docking 
experiment, Fexaramine was removed from the structure. A docking 
experiment was then performed using Fexaramine as ligand and the 
docking results showed that the predicted binding mode essentially 
matches the Fexaramine present in the experimental FXR 3-D struc-
ture, with a RMSD (Root Mean Standard Deviation) of less than 1 À 
on average, a cluster of 49 in 50 runs and a minimum binding energy 
of -14.39 kcal/mol. We also evaluate the FXR against other known 
agonists. These results valida te the use of the FXR 3D structure as a 
good target for virtual docking experiments with other potential 
ligands. 
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